Evidence map›Paper›PMID 35324065›Full record

ArticleLiver international : official journal of the International Association for the Study of the Liver2022

Alcohol-related hepatocellular carcinoma is a heterogenous condition: Lessons from a latent class analysis.

Charlotte E Costentin, Mélanie Minoves, Sylvain Kotzki, Olivier Farges, Nathalie Goutté, Thomas Decaens, Sébastien Bailly

Abstract read
In one paragraph

Article in Liver international : official journal of the International Association for the Study of the Liver, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Alcohol and Hepatocellular Carcinoma.Clinics in liver disease · 2024
    Review
  2. Alcohol-related hepatocellular carcinoma is a heterogenous condition: Lessons from a latent class analysis.Liver international : official journal of the International Association for the Study of the Liver · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Charlotte E CostentinInstitute for Advanced Biosciences, INSERM U1209/CNRS UMR, Grenoble Alpes University, Grenoble, France.ORCID 0000-0001-6115-8512
Mélanie MinovesHP2 Laboratory, INSERM U1300 and Grenoble Alpes University Hospital, Grenoble Alpes University, Grenoble, France.
Sylvain KotzkiHP2 Laboratory, INSERM U1300 and Grenoble Alpes University Hospital, Grenoble Alpes University, Grenoble, France.
Olivier FargesHepato-Biliary Surgery Department, Beaujon Hospital, Clichy, France.
Nathalie GouttéINSERM UMRS-1193, DHU Hépatinov and Centre Hépatobiliaire, Paul-Brousse Hospital, Assistance Publique - Hôpitaux de Paris Villejuif, Paris-Saclay University et DHU Hépatinov par FHU Hépatinov, Villejuif, France.
Thomas DecaensInstitute for Advanced Biosciences, INSERM U1209/CNRS UMR, Grenoble Alpes University, Grenoble, France.ORCID 0000-0003-0928-0048
Sébastien BaillyHP2 Laboratory, INSERM U1300 and Grenoble Alpes University Hospital, Grenoble Alpes University, Grenoble, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlcohol-associated hepatocellular carcinoma (AL-HCC) poor prognosis has been attributed to diagnosis at a later stage. However, host factors and specific health trajectories have been associated with severe outcomes in alcohol-related liver disease. We hypothesize AL-HCC is not a homogeneous condition but encompasses subgroups yielding different outcomes.

aimsOur aim was to provide a first attempt at a clinical phenotyping of AL-HCC.

methodsWe analysed data for the calendar years 2007-2013 from the French nationwide administrative hospital database. We selected patients with AL-HCC only. Clustering of AL-HCC phenotypes was performed by latent class analysis (LCA).

resultsThe study included 11 363 patients with AL-HCC, mainly male (89.6%), median age 67 years [IQR: 61; 74] of which 71.2% had at least one metabolic comorbidity. Five phenotypes were identified. Phenotype 1 (41.4%) displayed high rates of unrecognized cirrhosis prior to HCC diagnosis (81%), low rates of metabolic comorbidities (diabetes 13%), and mostly compensated liver disease at HCC diagnosis while the four other phenotypes displayed high rates of metabolic comorbidities (diabetes up to 100%), various patterns of liver disease trajectories and overall 42% unrecognized cirrhosis. In adjusted survival analysis, compared to phenotype 1, risk of death after HCC diagnosis was significantly different for all phenotypes.

conclusionLCA uncovers AL-HCC is a heterogeneous condition with distinct phenotypes yielding specific survival outcomes. Frequent unrecognized cirrhosis prior to HCC underlines the urgent need for implementing strategies to identify the underlying liver disease prior to HCC onset in patients with documented alcohol use disorders and metabolic comorbidities.

Indexed as

AlcoholismCarcinoma, HepatocellularDiabetes MellitusLiver NeoplasmsHumansLatent Class AnalysisLiver CirrhosisMaleRisk Factorsalcoholclusterliver cancersurvival

Identifiers

PMID35324065
PMCPMC9373918

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.